The role of the dopamine transporter in cocaine abuse

被引:0
|
作者
Sari Izenwasser
机构
[1] University of Miami School of Medicine,Department of Psychiatry and Behavioral Sciences
来源
Neurotoxicity Research | 2004年 / 6卷
关键词
Cocaine; Substance abuse; Dopamine; Dopamine Transporter; Behavioral sensitization; Locomotor activity;
D O I
暂无
中图分类号
学科分类号
摘要
There have been many studies aimed at understanding the role that the dopamine transporter plays in cocaine abuse. Most studies suggest that inhibition of dopamine uptake by cocaine is the primary mechanism by which its behavioral effects are produced. Because of the strong relationship between binding to the dopamine transporter and the behavioral effects of cocaine, the dopamine transporter has on occasion been referred to as the cocaine binding site. Chronic studies using cocaine or selective inhibitors of dopamine, norepinephrine, or serotonin uptake suggest that while a selective dopamine uptake inhibitor can produce sensitization to cocaine, the long-lasting sensitized response to a cocaine challenge observed in cocaine-pretreated rats is due to cocaine’s action on a system other than, or in addition to, dopamine. Thus, while dopamine appears to be important for the behavioral effects of cocaine, it appears that neurochemical systems other than dopamine likely play a role in the behavioral effects of chronic cocaine.
引用
收藏
页码:379 / 383
页数:4
相关论文
共 50 条
  • [1] The role of the dopamine transporter in cocaine abuse
    Izenwasser, S
    [J]. NEUROTOXICITY RESEARCH, 2004, 6 (05) : 379 - 383
  • [2] THE ROLE OF DOPAMINE IN COCAINE USE AND ABUSE
    WYATT, RJ
    KAROUM, F
    SUDDATH, R
    HITRI, A
    [J]. PSYCHIATRIC ANNALS, 1988, 18 (09) : 531 - 534
  • [3] Cocaine and the dopamine transporter
    Kuhar, MJ
    [J]. DRUG ABUSE IN THE DECADE OF THE BRAIN, 1997, : 207 - 212
  • [4] A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample
    Guindalini, C
    Howard, M
    Laranjeira, R
    Collier, D
    Ammar, N
    O'Gara, C
    Bubb, V
    Greenwood, T
    Kelsoe, J
    Asherson, P
    Murray, R
    Castelo, A
    Quinn, J
    Vallada, H
    Gerome, B
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 85 - 85
  • [5] A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample
    Guindalini, C
    Howard, M
    Haddley, K
    Laranjeira, R
    Collier, D
    Ammar, N
    Craig, I
    O'Gara, C
    Bubb, VJ
    Greenwood, T
    Kelsoe, J
    Asherson, P
    Murray, RM
    Castelo, A
    Quinn, JP
    Vallada, H
    Breen, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) : 4552 - 4557
  • [6] Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse
    Carroll, FI
    Howard, JL
    Howell, LL
    Fox, BS
    Kuhar, MJ
    [J]. AAPS JOURNAL, 2006, 8 (01): : E196 - E203
  • [7] Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse
    F. Ivy Carroll
    James L. Howard
    Leonard L. Howell
    Barbara S. Fox
    Michael J. Kuhar
    [J]. The AAPS Journal, 8
  • [8] Role of dopamine and norepinephrine transporter in the effect of cocaine: a microdialysis study
    Carboni, E
    Vacca, C
    Giros, B
    Di Chiara, G
    [J]. MONITORING MOLECULES IN NEUROSCIENCE, 2001, : 229 - 230
  • [9] DOPAMINE TRANSPORTER AND COCAINE ADDICTION
    POGUN, S
    [J]. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1994, 18 (02) : 139 - 139
  • [10] [11]Cocaine:: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy
    Fowler, JS
    Volkow, ND
    Wang, GJ
    Gatley, SJ
    Logan, J
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (05) : 561 - 572